jcobaya69 Profile Banner
Juan Carlos Obaya Profile
Juan Carlos Obaya

@jcobaya69

Followers
845
Following
4K
Statuses
11K

MEDICO DE FAMILIA. Doctor en Medicina Grupo Enfermedades Cardiovasculares semFYC. Master en Diabetes Universidad de Alcalá. Aquí mis opiniones personales.

Gijón, Spain
Joined February 2015
Don't wanna be here? Send us removal request.
@jcobaya69
Juan Carlos Obaya
1 day
RT @javierbutra: Adipose tissue in health and disease through the lens of its building blocks
0
6
0
@jcobaya69
Juan Carlos Obaya
1 day
RT @GiuseppeGalati_: 🔥 🗞️ #Beta_blockers in #HFmrEF & #HFpEF >16000 pts ✅ Association with ⬇️ #CV ☠️ & #HHF 🏥 in both groups ✳️ Be car…
0
25
0
@jcobaya69
Juan Carlos Obaya
1 day
RT @ValleAlfonso: 🫀 Beyond Medications: Nonpharmacologic Care in Heart Failure 🏃‍♂️🥗💤 A new review highlights key lifestyle strategies to…
0
26
0
@jcobaya69
Juan Carlos Obaya
2 days
RT @drbennisahmed: Outcomes of KDIGO-Defined CKD in U.S. Veterans With HFpEF, HFmrEF, and HFrEF These findings based on KDIGO-defined CKD…
0
6
0
@jcobaya69
Juan Carlos Obaya
2 days
RT @drgarymcgowan: Remnant Cholesterol in CAD Patients 🫀 RC was associated with ACM (HR 1.12), CV mortality (HR 1.20) & MACE (HR 1.10) acr…
0
2
0
@jcobaya69
Juan Carlos Obaya
2 days
RT @ESC_Journals: What’s the clinical impact of #AFib screening? This meta-analysis shows an increased detection and anticoagulation, lower…
0
16
0
@jcobaya69
Juan Carlos Obaya
2 days
RT @ZHeart11768530: 🔴Early combination therapy with SGLT2is and GLP-1 RA or dual GIP/GLP-1 RA in type 2 diabetes⤵️ #2025Review #FreeToRead
0
9
0
@jcobaya69
Juan Carlos Obaya
2 days
RT @ZHeart11768530: 🔴Personalized Intervention Based on Early Detection of Atherosclerosis: JACC State-of-the-Art #2024Review #OpenAccess
0
15
0
@jcobaya69
Juan Carlos Obaya
2 days
0
129
0
@jcobaya69
Juan Carlos Obaya
2 days
RT @TheLancetEndo: Adverse #skeletal effects of some forms of #bariatric surgery are well documented, but the effects of incretin-based the…
0
24
0
@jcobaya69
Juan Carlos Obaya
2 days
RT @cardiotipss: 📍 Anticoagulantes ‼️ 🎡 Elegir el anticoagulante más adecuado según el perfil del paciente. ✴️ Apixaban: Ancianos, obesid…
0
195
0
@jcobaya69
Juan Carlos Obaya
2 days
RT @MWeintraubMD: SGLT2 inhibitors paradoxically have greater cardiovascular protection in older adults compared to younger adults with T2D…
0
118
0
@jcobaya69
Juan Carlos Obaya
2 days
RT @drbennisahmed: Semaglutide Improves Cardiovascular Outcomes in Patients With History of Coronary Artery Bypass Graft and Obesity Semag…
0
9
0
@jcobaya69
Juan Carlos Obaya
2 days
RT @JACCJournals: The enigmata of cardioprotection with #SGLT2i Read the editorial by Drs. Heusch & @PKleinbongard on a new #JACCBTS study…
0
85
0
@jcobaya69
Juan Carlos Obaya
2 days
RT @RitikaTuliMD: #CardioNugget 39/365 🚨 New #AtrialFibrillation Classification 🚨 AF is now seen as a progressive disease, emphasizing ea…
0
103
0
@jcobaya69
Juan Carlos Obaya
2 days
RT @JasmineNephro: 🫘Approach to Resistant Hypertension
Tweet media one
0
131
0
@jcobaya69
Juan Carlos Obaya
2 days
RT @SeguraCardio: 📌 Novel pharmacological approaches to lowering blood pressure & managing #hypertension #HTN #HTA
Tweet media one
0
16
0
@jcobaya69
Juan Carlos Obaya
2 days
2
0
2
@jcobaya69
Juan Carlos Obaya
2 days
RT @SABOURETCardio: Kind reminder to analyse a RCT on #LLT : consider baseline hashtag#CVR, magnitude of #LDL decrease and #TimeExposure to…
0
7
0
@jcobaya69
Juan Carlos Obaya
2 days
0
6
0